Mingjiong Zhang

665 citations
24 papers · 502 indexed · h-index 12
Topics
Cancer-related molecular mechanisms research (11 papers)RNA modifications and cancer (7 papers)Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers)

In The Last Decade

Mingjiong Zhang

22 papers receiving 501 citations

Peers

Mingjiong Zhang
Comparison fields: 5 of 62
  • Molecular Biology 275
  • Cancer Research 227
  • Oncology 152
  • Immunology 97
  • Pulmonary and Respiratory Medicine 79
Replace Christian Vay with:
Christian Vay Germany
Hiromitsu Komiyama Japan
Shineng Zhang China
Bo Gong Japan
Simon Rieder Germany
Gian Luca Rampioni Vinciguerra Italy
Xianchao Lin China
Prabhu Arumugam United Kingdom
Chunfu Zhu China
Daniela Bianconi Austria
Mingjiong Zhang relative to Christian Vay Germany Christian Vay's profile →
Citations per field
00.5×5.3×
Christian Vay · 1×
Citations per year

Countries citing papers authored by Mingjiong Zhang

Since Specialization
Citations

This map shows the geographic impact of Mingjiong Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingjiong Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingjiong Zhang more than expected).

Fields of papers citing papers by Mingjiong Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingjiong Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingjiong Zhang. The network helps show where Mingjiong Zhang may publish in the future.

Co-authorship network of co-authors of Mingjiong Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Mingjiong Zhang. A scholar is included among the top collaborators of Mingjiong Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingjiong Zhang. Mingjiong Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2 0
3 3
4 11
5 1
6 10
7 1
8 32
9 16
10 11
11 14
12 41
13 19
14 5
15 82
16 44
17 62
18 3
19 40
20 0

About Mingjiong Zhang

Mingjiong Zhang is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 24 papers that have together received 502 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (7 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). The work is most often cited by research in Cancer Research (227 citations), Oncology (152 citations) and Immunology (97 citations). Mingjiong Zhang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Ni Wang, Quanpeng Li, Yang Yu, Lin Miao, Qi Tang, Lizhou Jia, Xiaochen Huang, Jian Yang, Wei Zhao and Jin Zhu. Their work appears in journals such as Nature Communications, Medicine and Cell Death and Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026